–CanSeq150 Initiative will use 10x Genomics’ Chromium de novo Assembly Solution to generate high quality, cost-effective assemblies for new genomes– PLEASANTON, CA.—10x Genomics, a company focused on accelerating genomic discovery, announced today a partnership with the CanSeq150 Initiative, a sequencing initiative by Canada’s Genomics Enterprise (CGEn). CanSeq150 aims to sequence 150 new genomes to support […]
DANVERS, MA. Cell Signaling Technology (CST), a leading provider of antibodies, kits, and services, has opened a new office in Shanghai China to support the rapidly expanding China life science market and the growth of the CST business in the country. The new facility triples the office and warehouse footprint and will feature CST’s Global […]
DANVERS, MA — Cell Signaling Technology (CST), a leading provider of antibodies, kits, and services, has opened a new office in Shanghai China to support the rapidly expanding China life science market and the growth of the CST business in the country. The new facility triples the office and warehouse footprint and will feature CST’s […]
Dundee, UK: Ubiquigent Limited announced today that it has entered into a multi-year strategic R&D collaboration agreement with FORMA Therapeutics for the design and development of novel deubiquitylase (DUB) enzyme inhibitors. Under the terms of the collaboration agreement, Ubiquigent will receive an upfront payment with research support and is eligible for possible additional milestones payments. […]
Collaboration will support translational research that demonstrates the value of PGx in precision medicine PITTSBURGH — Thermo Fisher Scientific and the University of Pittsburgh have established a new Pharmacogenomics (PGx) Center of Excellence that combines expertise and technology in genomics, bioinformatics, implementation science, medication response phenotyping and education. The Center aims to discover and validate medication response predictors in […]
WALTHAM, Massachusetts – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that Parent Project Muscular Dystrophy (PPMD) has selected the Company to provide genetic testing for its Decode Duchenne program. Duchenne muscular dystrophy (Duchenne) is the most common genetic disorder diagnosed in childhood, affecting approximately 1 in every 5,000 live male births (about 20,000 new […]
Biologists can now use SnapGene software to order plasmids directly through VectorBuilder. CHICAGO–GSL Biotech and VectorBuilder have formed a partnership to create a complete cloning solution, allowing customers to order their entire custom plasmids directly from VectorBuilder through GSL Biotech’s “SnapGene” software. SnapGene was created to meet the everyday needs of molecular biologists to plan, visualize, and document […]
– Agreement covers supply and support of Miltenyi Biotec Prodigy® platform for the manufacture of Autolus programmed T cell therapies – London – Autolus Limited (“Autolus”), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer, and Miltenyi Biotec GmbH (“Miltenyi Biotec”), a global provider of products and services that advance […]
New grants will accelerate DNA Script’s commercialization of its novel high speed, high efficiency, free-of-harsh-chemicals DNA synthesis technology. Paris, France – DNA Script today announced awards totaling $5.5M in non-dilutive financing from the highly selective Horizon 2020 European Innovation Council program of the European Commission and the Aide au développement de l’innovation and Concours Mondial d’innovation programs of Bpifrance. DNA Script […]
Connection Capital, the specialist private client investment business, has raised £5.9m from its private investor clients to invest in a specialist laboratory equipment manufacturer with a global blue chip client base. HEL Ltd (HEL) designs and supplies a range of custom-made modular lab instruments and testing equipment. Typical products include different forms of “reaction stations” […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
